These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35864570)

  • 1. Serum per- and polyfluoroalkyl substance concentrations in four municipal US fire departments.
    Burgess JL; Fisher JM; Nematollahi A; Jung AM; Calkins MM; Graber JM; Grant CC; Beitel SC; Littau SR; Gulotta JJ; Wallentine DD; Hughes RJ; Popp C; Calafat AM; Botelho JC; Coleman AD; Schaefer-Solle N; Louzado-Feliciano P; Oduwole SO; Caban-Martinez AJ
    Am J Ind Med; 2023 May; 66(5):411-423. PubMed ID: 35864570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2021 Dec; 157():106789. PubMed ID: 34333293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of legacy and emerging per- and polyfluoroalkyl substances in the Anniston Community Health Surveys (ACHS I and ACHS II).
    Petriello MC; Mottaleb MA; Serio TC; Balyan B; Cave MC; Pavuk M; Birnbaum LS; Morris AJ
    Environ Int; 2022 Jan; 158():106907. PubMed ID: 34763231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
    Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
    Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum per- and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area, Georgia.
    Chang CJ; Ryan PB; Smarr MM; Kannan K; Panuwet P; Dunlop AL; Corwin EJ; Barr DB
    Environ Res; 2021 Jul; 198():110445. PubMed ID: 33186575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014-2016 and comparison with the National Health and Nutrition Examination Survey (NHANES).
    Schultz AA; Stanton N; Shelton B; Pomazal R; Lange MA; Irving R; Meiman J; Malecki KC
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):766-777. PubMed ID: 37580384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
    Calafat AM; Wong LY; Kuklenyik Z; Reidy JA; Needham LL
    Environ Health Perspect; 2007 Nov; 115(11):1596-602. PubMed ID: 18007991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
    Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
    Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Per- and Polyfluoroalkyl Substance and Cardio Metabolic Markers in Firefighters.
    Khalil N; Ducatman AM; Sinari S; Billheimer D; Hu C; Littau S; Burgess JL
    J Occup Environ Med; 2020 Dec; 62(12):1076-1081. PubMed ID: 33105404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
    Ye X; Kato K; Wong LY; Jia T; Kalathil A; Latremouille J; Calafat AM
    Int J Hyg Environ Health; 2018 Jan; 221(1):9-16. PubMed ID: 28993126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal decline in serum PFAS concentrations among metropolitan firefighters: Longitudinal study on post-exposure changes following PFAS foam cessation.
    Mesfin Tefera Y; Gaskin S; Mitchell K; Springer D; Mills S
    Environ Int; 2023 Sep; 179():108167. PubMed ID: 37651929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Predictors of Per- and Polyfluoroalkyl Substances (PFAS) Serum Levels among Members of a Suburban US Volunteer Fire Department.
    Graber JM; Black TM; Shah NN; Caban-Martinez AJ; Lu SE; Brancard T; Yu CH; Turyk ME; Black K; Steinberg MB; Fan Z; Burgess JL
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33918459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate concentrations and serum perfluoroalkyl and polyfluoroalkyl substance concentrations in adolescents and adults in the USA (National Health and Nutrition Examination Study 2003-16): an observational study.
    Zhang Y; Mustieles V; Wang YX; Sun Y; Agudelo J; Bibi Z; Torres N; Oulhote Y; Slitt A; Messerlian C
    Lancet Planet Health; 2023 Jun; 7(6):e449-e458. PubMed ID: 37286242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
    Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
    Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of serum half-lives for linear and branched perfluoroalkyl substances after long-term high exposure-A study in Ronneby, Sweden.
    Li Y; Andersson A; Xu Y; Pineda D; Nilsson CA; Lindh CH; Jakobsson K; Fletcher T
    Environ Int; 2022 May; 163():107198. PubMed ID: 35447437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey.
    Calafat AM; Kato K; Hubbard K; Jia T; Botelho JC; Wong LY
    Environ Int; 2019 Oct; 131():105048. PubMed ID: 31376596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.